SCHEMBL4866404

SCHEMBL4866404

CN1CCC(Sc2ccc(NS(=O)(=O)c3ccc4ccccc4c3)cc2)CC1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.55
HTR1A P08908 1/20 0.55
HTR2A P28223 1/20 0.55
HTR2C P28335 1/20 0.55
HTR7 P34969 1/20 0.55
DRD3 P35462 1/20 0.55
ATM Q13315 1/20 0.55
ALDH1A1 P00352 2/20 0.53
MEN1 O00255 2/20 0.53
MAPT P10636 2/20 0.53
KMT2A Q03164 2/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
LMNA P02545 2/20 0.51
GAA P10253 1/20 0.51
PKM P14618 1/20 0.50
PKLR P30613 1/20 0.50
PGR P06401 1/20 0.50
NLRP3 Q96P20 1/20 0.49
RAD52 P43351 1/20 0.47
HDAC3 O15379 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4868720 0.83 MAPT (0.49) HTR6HTR2AHTR2CDRD3ALDH1A1
SCHEMBL4873426 0.83 PGR (0.55) ALDH1A1SMN1; SMN2LMNAGAAPKM
SCHEMBL4874458 0.82 ALDH1A1 (0.44) HTR6HTR2AHTR2CDRD3ATM
SCHEMBL4866321 0.82 ALDH1A1 (0.57) ATMALDH1A1MEN1MAPTKMT2A
SCHEMBL4870984 0.82 PGR (0.48) HTR6HTR1AHTR7MEN1KMT2A
SCHEMBL4876786 0.82 ALDH1A1 (0.56) HTR6HTR2AHTR2CDRD3ALDH1A1
SCHEMBL6617076 0.82 ALDH1A1 (0.60) ALDH1A1MEN1MAPTKMT2ASMN1; SMN2
SCHEMBL4876689 0.81 CES1 (0.54) HTR6HTR2AHTR2CDRD3ALDH1A1
SCHEMBL4876385 0.81 HTR6 (0.49) HTR6HTR1AHTR2AHTR2CHTR7
SCHEMBL4873695 0.81 ALDH1A1 (0.58) HTR2AHTR2CALDH1A1MEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7408067-B2 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK + CO., INC. (US) 2008-08-05 US disclosed
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors MERCK SHARP & DOHME CORP. 2005-03-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050070520-A1 Aza-cyclic compounds as modulators of acetylcholine receptors CHRNG, CHRNA4, CHRNB4 HTR6 335/4885HTR1A 417/4885HTR2A 529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.